SLC22A1 and hepatocellular carcinoma: Subsequently, five genes (C6, UGT2B7, SLC22A1, F11, and CYP2C8) were identified as potential novel diagnostic biomarkers and four genes (CYS2, F11, ANXA10, and SLC22A1) were identified as potential novel prognostic biomarkers in HCC.